Swiss National Bank
IDIX

Swiss National Bank’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Swiss National Bank’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-86,600
Closed -$2.09M – 2540
2014
Q2 		$2.09M Sell
86,600
-12,000
-12% -$125K 0.01% 1229
2014
Q1 		$595K Hold
98,600
– – ﹤0.01% 2033
2013
Q4 		$590K Hold
98,600
– – ﹤0.01% 1880
2013
Q3 		$514K Sell
98,600
-6,100
-6% -$26.7K ﹤0.01% 1917
2013
Q2 		$378K Buy
+104,700
New +$428K ﹤0.01% 2098

Swiss National Bank's IDIX Position: Q3 2014 in Review

Swiss National Bank sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 86,600 shares — an estimated $2.09M sold.

Swiss National Bank first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.09M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Swiss National Bank reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Swiss National Bank sold 86,600 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.09M.
  • Swiss National Bank first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Swiss National Bank's IDENIX PHARMACEUTICALS INC position peaked at $2.09M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.